UBRELVY
NDC 0023-6501 · Allergan, Inc.
Generic nameubrogepant
Dosage formTABLET
RouteORAL
Active ingredient(s)UBROGEPANT
Strength100 mg/1
Pharmacologic classCalcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]
Marketing categoryNDA
Packages
0023-6501-01 — 1 PACKET in 1 BOX (0023-6501-01) / 1 TABLET in 1 PACKET
0023-6501-10 — 10 PACKET in 1 BOX (0023-6501-10) / 1 TABLET in 1 PACKET (0023-6501-02)
0023-6501-16 — 16 PACKET in 1 BOX (0023-6501-16) / 1 TABLET in 1 PACKET (0023-6501-02)
0023-6501-30 — 30 PACKET in 1 BOX (0023-6501-30) / 1 TABLET in 1 PACKET (0023-6501-02)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0023-6498 — ubrogepant